Amgen Spends US$1.9 B on Five Prime to Boost Cancer Pipeline
By Michelle Liu
Pharma Deals Review: Vol 2021 Issue 3 (Table of Contents)
Published: 11 Mar-2021
DOI: 10.3833/pdr.v2021.i3.2598 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest M&A deal since it paid US$10...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018